# Church & Dwight Co Inc: Form 10-Q for the period ended Sep 30, 2018

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2018-11-01
- Accepted by EDGAR: Nov 1, 2018, 16:13 ET
- Period: 2018-09-30
- Accession: 0001564590-18-026089
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459018026089/chd-10q_20180930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459018026089/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-07-01 to 2018-09-30 | $1.04bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2018-01-01 to 2018-09-30 | $3.07bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-07-01 to 2018-09-30 | $577.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2018-01-01 to 2018-09-30 | $1.71bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2018-07-01 to 2018-09-30 | $460.1m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2018-01-01 to 2018-09-30 | $1.37bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-07-01 to 2018-09-30 | $23.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2018-01-01 to 2018-09-30 | $64.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-07-01 to 2018-09-30 | $135.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2018-01-01 to 2018-09-30 | $411.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-07-01 to 2018-09-30 | $204.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2018-01-01 to 2018-09-30 | $598.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-07-01 to 2018-09-30 | $19.4m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2018-01-01 to 2018-09-30 | $59.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-07-01 to 2018-09-30 | $41.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2018-01-01 to 2018-09-30 | $117.6m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.58 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2018-01-01 to 2018-09-30 | $1.70 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-07-01 to 2018-09-30 | $0.60 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2018-01-01 to 2018-09-30 | $1.74 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-07-01 to 2018-09-30 | 251,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2018-01-01 to 2018-09-30 | 250,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2018-01-01 to 2018-09-30 | $568.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2018-01-01 to 2018-09-30 | $30.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2018-01-01 to 2018-09-30 | $159.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2018-01-01 to 2018-09-30 | $200.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-09-30 | $188.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-09-30 | $960.3m | us-gaap:AssetsCurrent |
| Total assets | at 2018-09-30 | $5.97bn | us-gaap:Assets |
| Current liabilities | at 2018-09-30 | $1.03bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-09-30 | $3.61bn | us-gaap:Liabilities |
| Long-term debt | at 2018-09-30 | $1.80bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-09-30 | $299.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2018-09-30 | $1.7m | us-gaap:ShortTermBorrowings |

## Management's discussion and analysis

As filed, 29,127 characters.

#### Recent Developments

#### Passport Acquisition

On March 8, 2018, we purchased Passport Food Safety Solutions, Inc. (“Passport”). Passport sells products for pre- and post-harvest treatment in the poultry, swine, and beef production markets (the “Passport Acquisition”). The total purchase price was approximately $50.0, which is subject to an additional payment of up to $25.0 based on sales performance through 2020 and a working capital adjustment. Passport’s annual sales were approximately $21.0 in 2017. The acquisition was funded with short-term borrowings and is managed in the Specialty Products (“SPD”) segment.

### Results of Operations

### Consolidated results

|  | Three Months Ended September 30, 2018 | Change vs. Prior Year | Three Months Ended September 30, 2017 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$1,037.6** | 7.2% | $967.9 |
| **Gross Profit** | **$460.1** | 4.9% | $438.5 |
| Gross Margin | **44.3%** | -100 basis points | 45.3% |
| **Marketing Expenses** | **$120.5** | 7.7% | $111.9 |
| Percent of Net Sales | **11.6%** | 0 basis points | 11.6% |
| **Selling, General & Administrative Expenses** | **$135.4** | 5.9% | $127.9 |
| Percent of Net Sales | **13.0%** | -20 basis points | 13.2% |
| **Income from Operations** | **$204.2** | 2.8% | $198.7 |
| Operating Margin | **19.7%** | -80 basis points | 20.5% |
| **Net income per share - Diluted** | **$0.58** | 11.5% | $0.52 |
|  | **Nine Months Ended** | **Change vs.** | **Nine Months Ended** |
|  | **September 30, 2018** | **Prior Year** | **September 30, 2017** |
| **Net Sales** | **$3,071.5** | 12.0% | $2,743.1 |
| **Gross Profit** | **$1,366.5** | 9.5% | $1,248.2 |
| Gross Margin | **44.5%** | -100 basis points | 45.5% |
| **Marketing Expenses** | **$356.8** | 7.0% | $333.6 |
| Percent of Net Sales | **11.6%** | -60 basis points | 12.2% |
| **Selling, General & Administrative Expenses** | **$411.4** | 3.7% | $396.6 |
| Percent of Net Sales | **13.4%** | -100 basis points | 14.4% |
| **Income from Operations** | **$598.3** | 15.5% | $518.0 |
| Operating Margin | **19.5%** | +60 basis points | 18.9% |
| **Net income per share - Diluted** | **$1.70** | 28.8% | $1.32 |

22

Diluted Net Income per share was $0.58 as compared to $0.52 in the third quarter of 2017. Diluted Net Income per share was $1.70 in the first nine months of 2018 as compared to $1.32 in the same period in 2017. During the first quarter of 2017, we sold our chemical business in Brazil, and recorded a pre- and post- tax charge of $3.5 ($1.3 in cost of goods sold and $2.2 in selling, general and administrative expenses). This equated to $0.01 per share. During the second quarter of 2017, we completed the termination of and settled an international pension plan. As a result, we recorded a pre-tax charge of $39.2 ($31.5 after tax) which equated to $0.12 per share. During the third quarter of 2017, we reversed a tax valuation allowance of $7.6 ($0.03 per share) established in 2015 in connection with the impairment of our remaining investment in the Natronx Technologies LLC (“Natronx”) joint venture.

#### Net Sales

Net sales for the quarter ended September 30, 2018 were $1,037.6, an increase of $69.7 or 7.2% as compared to the same period in 2017. Net sales for the nine months ended September 30, 2018 were $3,071.5, an increase of $328.4 or 12.0% over the comparable nine month period of 2017. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 |
| --- | ---: | ---: |
| Product volumes sold | 2.8% | 4.0% |
| Pricing/Product mix | 1.9% | 0.3% |
| Foreign exchange rate fluctuations | (0.5)% | 0.4% |
| Volume from acquired product lines (net of divestiture) (1) | 3.0% | 7.3% |
| **Net Sales increase** | **7.2%** | **12.0%** |

(1) On March 8, 2018, we acquired Passport. On January 17, 2017, we acquired the Viviscal business (the “Viviscal Acquisition”). On May 1, 2017, we acquired Agro BioSciences, Inc. (the “Agro Acquisition”). On August 7, 2017, we acquired Pik Holdings, Inc. (the “Waterpik Acquisition”). Net sales of these acquisitions are included in our results since the date of acquisition. In March 2017, we sold our chemical business in Brazil.

For the three and nine months ended September 30, 2018, the volume change primarily reflects increased product sales in both the Consumer Domestic and Consumer International segments, with volume declines in Specialty Products. For the three months ended September 30, 2018, favorable price/mix in the Consumer Domestic and SPD segments were partially offset by unfavorable price/mix in the Consumer International segment. For the nine months ended September 30, 2018, unfavorable price/mix in the Consumer Domestic segment was partially offset by favorable price/mix in the Consumer International and SPD segments.

#### Gross Profit / Gross Margin

Our gross profit was $460.1 for the three months ended September 30, 2018, a $21.6 increase as compared to the same period in 2017. Gross margin decreased 100 basis points (“bps”) in the third quarter of 2018 compared to the same period in 2017, primarily due to higher commodity and transportation costs of 230 bps, and other manufacturing cost increases of 60 bps, partially offset by productivity programs of 100 bps and favorable price/mix of 90 bps. Gross profit was $1,366.5 for the nine months ended September 30, 2018, a $118.3 increase compared to the same period of 2017. Gross margin decreased 100 bps to 44.5% in the first nine months of 2018 compared to the same period in 2017, primarily due to higher commodity costs and transportation costs of 160 bps, and other manufacturing cost increases of 50 bps, partially offset by productivity programs of 80 bps, favorable price/mix of 20 bps, and favorable foreign exchange rates of 10 bps. The impact of acquired businesses and price/mix includes charges associated with a voluntary recall and a FDA mandated withdrawal for certain oral care products.

#### Operating Expenses

Marketing expenses for the three months ended September 30, 2018 were $120.5, an increase of $8.6 or 7.7% as compared to the same period in 2017. Marketing expenses as a percentage of net sales in the third quarter of both 2018 and 2017 were 11.6% due to 80 bps of leverage on higher net sales offset by 80 bps on higher expenses. Marketing expenses for the first nine months of 2018 were $356.8, an increase of $23.2 as compared to the same period in 2017. Marketing expenses as a percentage of net sales for the first nine months of 2018 decreased by 60 bps to 11.6% as compared to 12.2% in the same period in 2017 due to 130 bps of leverage on higher net sales partially offset by 70 bps on higher expenses. Recent acquisitions have a lower percentage of sales spend rate.

Selling, general and administrative (“SG&A”) expenses were $135.4 in the third quarter of 2018, an increase of $7.5 or 5.9% as compared to the same period in 2017. The increase is primarily due to the transition and ongoing costs associated with the recent acquisitions, along with higher compensation, information systems (in part in support of new technologies and security upgrades) and research and development (“R&D”) costs. SG&A as a percentage of net sales decreased 20 bps to 13.0% in the third quarter of 2018 as compared to 13.2% in the same period in 2017. The decrease is due 90 bps of leverage associated with higher sales, partially offset by higher costs of 70 bps. SG&A for the first nine months of 2018 was $411.4, an increase of $14.8 as compared to the same period in 2017. The prior year includes the $39.2 international pension settlement charge. The increase is primarily due to transition and ongoing acquisition-related costs, higher compensation, information system (in part in support of new technologies and security upgrades) and R&D costs and costs associated with selling our chemical business in Brazil. SG&A as a percentage of net sales decreased 100 bps to 13.4% in the first nine months of 2018 compared to 14.4% in 2017 due to 150 bps of leverage associated with higher sales partially offset by higher costs of 50 bps. The comparison is helped by 140 bps associated with the 2017 pension settlement charge.

#### Other Income and Expenses

Other expense, net for the three and nine months ended September 30, 2018 increased $1.5 and $3.6, respectively, compared to the same period in 2017 primarily due to the effect of changes in foreign exchange rates.

Interest expense for the three and nine months ended September 30, 2018 increased $3.0 and $25.8, respectively, as compared to the same period in 2017 due to a higher amount of average debt outstanding primarily associated with the $1,425.0 aggregate principal amount of Senior Notes completed on July 25, 2017.

#### Income Taxes

The effective tax rate for the three and nine months ended September 30, 2018 was 21.9% and 21.6% respectively, compared to 28.7% and 31.6% in the same periods in 2017. The decrease in the tax rate for both periods is primarily due to the Tax Cuts and Jobs Act (the “Tax Act”) enacted in December 2017, which lowered the U.S. statutory tax rate from 35% to 21%.

The tax rate for the three and nine months ended September 30, 2017 was reduced by 400 bps and 150 bps respectively from the reversal of a valuation allowance against the tax benefit related to the Natronx impairment charge. The benefit from the Natronx impairment charge for the nine months ended September 30, 2017 was partially offset by the international pension settlement charge representing 90 bps.

### Segment results

We operate three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. We also have a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings of affiliates. As of September 30, 2018, we held 50% ownership interests in each of Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), respectively. Our equity in earnings of Armand and ArmaKleen for the three and nine months ended September 30, 2018 and 2017 are included in the Corporate segment.

Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and nine months ended September 30, 2018 and September 30, 2017 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Third Quarter 2018** | **$784.9** | **$174.1** | **$78.6** | **$0.0** | **$1,037.6** |
| Third Quarter 2017 | 729.2 | 162.8 | 75.9 | 0.0 | 967.9 |
| **First Nine Months of 2018** | **$2,310.4** | **$530.9** | **$230.2** | **$0.0** | **$3,071.5** |
| First Nine Months of 2017 | 2,067.1 | 451.0 | 225.0 | 0.0 | 2,743.1 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Third Quarter 2018** | **$149.6** | **$21.9** | **$13.3** | **$2.5** | **$187.3** |
| Third Quarter 2017 | 146.9 | 23.6 | 13.8 | 2.7 | 187.0 |
| **First Nine Months of 2018** | **$428.3** | **$67.6** | **$40.5** | **$7.0** | **$543.4** |
| First Nine Months of 2017(3) | 431.5 | 19.3 | 35.3 | 7.9 | 494.0 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $1.9 and $1.5 for the three months ended September 30, 2018 and September 30, 2017, respectively, and were $4.5 and $4.2 for the nine months ended September 30, 2018 and September 30, 2017, respectively.

(2) In determining Income before Income Taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among the segments based upon each segment’s relative Income from Operations.

(3) Includes a pension settlement charge of $39.2 recorded in Consumer International.

Product line revenues from external customers are as follows:

|  | Three Months Ended September 30, 2018 | September 30, 2017 | Nine Months Ended September 30, 2018 | September 30, 2017 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$448.9** | $423.3 | **$1,291.8** | $1,228.6 |
| Personal Care Products | **336.0** | 305.9 | **1,018.6** | 838.5 |
| Total Consumer Domestic | **784.9** | 729.2 | **2,310.4** | 2,067.1 |
| Total Consumer International | **174.1** | 162.8 | **530.9** | 451.0 |
| Total SPD | **78.6** | 75.9 | **230.2** | 225.0 |
| **Total Consolidated Net Sales** | **$1,037.6** | $967.9 | **$3,071.5** | $2,743.1 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the third quarter of 2018 were $784.9, an increase of $55.7 or 7.6% as compared to the same period in 2017. Consumer Domestic net sales for the nine months ended September 30, 2018 were $2,310.4 an increase of $243.3 or 11.8% as compared to the same period in 2017. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 |
| --- | ---: | ---: |
| Product volumes sold | 2.6% | 4.6% |
| Pricing/Product mix | 2.1% | (0.2%) |
| Volume from acquired product lines (1) | 2.9% | 7.4% |
| **Net Sales increase** | **7.6%** | **11.8%** |

(1) Includes net sales of the brands acquired in the Viviscal Acquisition and the Waterpik Acquisition since the dates of acquisition.

The increase in net sales for the three months ended September 30, 2018, reflects the impact of acquisitions, higher sales of ARM & HAMMER liquid and unit dose laundry detergent, ARM & HAMMER clumping cat litter, VITAFUSION and L’IL CRITTERS gummy vitamins, OXICLEAN stain fighters, and XTRA laundry detergent, partially offset by lower sales of KABOOM cleaning products. The increase in net sales for the nine month period ending September 30, 2018, reflects higher sales of ARM & HAMMER liquid and unit dose laundry detergent, ARM & HAMMER Cat Litter, BATISTE dry shampoo, VITAFUSION and L’IL CRITTERS gummy vitamins, VIVISCAL hair care business and XTRA laundry detergent, partially offset by lower sales of KABOOM cleaning products.

There continues to be significant product and price competition in the premium and deep value laundry detergent categories and more recently, product competition in the gummy vitamin category. For example, in the laundry detergent category, P&G and Henkel, the two largest laundry detergent companies in the U.S., are engaged in aggressive pricing promotions, and retailers are continuing to de-emphasize the deep value tier of laundry detergents, which is where XTRA competes. In addition, the gummy vitamin category has grown from eight competitors to 30 in the last five years. We continue to evaluate and vigorously combat these pressures through, among other things, new product introductions and increased marketing and trade spending. However, there is no assurance the categories will not decline in the future and that we will be able to offset any such decline.

Consumer Domestic income before income taxes for the third quarter of 2018 was $149.6, a $2.7 increase as compared to the third quarter of 2017. The increase is due primarily to higher sales volumes of $22.2 and favorable price/mix of $8.8, partially offset by unfavorable manufacturing and distribution costs of $14.1, higher marketing expenses of $6.0, higher SG&A of $5.1 (primarily associated with the acquisitions and higher information systems and R&D costs), and higher interest and other expenses of $2.9. The impact of acquired businesses and price/mix includes charges associated with a voluntary recall and a FDA mandated withdrawal for certain oral care products. For the nine month period ended September 30, 2018, income before income taxes was $428.3, a $3.2 decrease as compared to the first nine months of 2017. The decrease is due primarily to higher SG&A of $39.3 (also associated with the acquisitions and higher information systems and R&D costs), unfavorable manufacturing and distribution costs of $30.5, higher interest and other expenses of $21.8, unfavorable price/mix (consisting of higher trade promotion spending) of $18.0 and higher marketing expenses of $17.1, partially offset by the impact of higher sales volumes of $123.7. The impact of acquired businesses and price/mix includes charges associated with a voluntary recall and a FDA mandated withdrawal for certain oral care products.

### Consumer International

Consumer International net sales were $174.1 in the third quarter of 2018, an increase of $11.3 or 6.9% as compared to the same period in 2017. Consumer International net sales in the first nine months of 2018 were $530.9, an increase of $79.9 or approximately 17.7% as compared to the same period in 2017. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 |
| --- | ---: | ---: |
| Product volumes sold | 8.5% | 6.1% |
| Pricing/Product mix | (0.2%) | 1.2% |
| Foreign exchange rate fluctuations / Other | (3.2)% | 2.2% |
| Volume from acquired product lines (1) | 1.8% | 8.2% |
| **Net Sales increase** | **6.9%** | **17.7%** |

(1) Includes net sales of the brands acquired in the Viviscal Acquisition and the Waterpik Acquisition since the dates of acquisition.

Excluding the impact of foreign exchange rates and acquisitions, higher sales in the third quarter ended September 30, 2018 were primarily due to BATISTE, VITAFUSION & L’IL CRITTERS, FEMFRESH and OXICLEAN in the export business, BATISTE, ARM & HAMMER cat litter, VITAFUSION & L’IL CRITTERS in Canada, BATISTE and STERIMAR in the UK, and ARM & HAMMER liquid laundry detergent, dental care and OXICLEAN in Mexico. For the nine months ended September 30, 2018 higher sales primarily occurred in exports, Canada, and Mexico, and were attributable to BATISTE, OXICLEAN, ARM & HAMMER liquid laundry detergent, cat litter and baking soda.

Consumer International income before income taxes was $21.9 in the third quarter 2018, a decrease of $1.7 compared to the same period in 2017 due primarily to higher costs as a result of the higher marketing expenses of $3.6, unfavorable manufacturing costs of $2.2, higher SG&A costs of $1.9, unfavorable price/mix of $0.5, unfavorable foreign exchange rates of $0.4, and higher interest and other expenses of $1.4, partially offset by higher sales volumes of $8.5. For the first nine months of 2018, income before income taxes was $67.6, a $48.3 increase as compared to the same period in 2017, due primarily to lower costs as a result of the 2017 pension settlement of $39.2, higher sales volumes of $33.9, favorable foreign exchange rates of $3.6, partially offset by higher SG&A costs of $11.4, unfavorable manufacturing costs of $6.3, higher marketing expenses of $4.7, and a higher interest and other expenses of $5.3.

### Specialty Products (“SPD”)

SPD net sales were $78.6 in the third quarter of 2018, an increase of $2.7 or 3.6% as compared to the same period in 2017. SPD net sales were $230.2 for the first nine months of 2018, an increase of $5.2, or 2.3% as compared to the same period of 2017. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 |
| --- | ---: | ---: |
| Product volumes sold | (8.3)% | (6.4)% |
| Pricing/Product mix | 5.0% | 3.2% |
| Volume from acquired product lines (net of divestiture) (1) | 6.9% | 5.5% |
| **Net Sales increase** | **3.6%** | **2.3%** |

(1) Includes net sales of Passport and Agro BioSciences, Inc. since the dates of acquisition and is negatively impacted by the sale of our Brazilian chemical business.

Excluding the impact of the acquisitions and divestiture, the net sales decrease in the third quarter and nine month period of 2018 was driven by lower volumes in the animal productivity business, partially offset by higher broad-based pricing. Demand in the dairy industry is significantly reduced due to low milk prices.

SPD income before income taxes was $13.3 in the third quarter of 2018, a decrease of $0.5 as compared to the same period in 2017 due to higher SG&A costs of $2.9, unfavorable manufacturing costs of $0.8, lower sales volumes of $0.5, higher interest expense of $0.2, partially offset by favorable price/product mix of $3.8 and lower marketing costs of $0.2. SPD income before income taxes was $40.5 in the first nine months of 2018, an increase of $5.2 as compared to the same period in 2017 due primarily to favorable price/product mix of $7.1, higher sales volumes of $4.2, lower costs as a result of the 2017 sale of our Brazilian business of $3.5, lower manufacturing costs of $2.7 (in part due to the change in inventory valuation methodology), partially offset by higher SG&A costs of $9.9, and a higher interest expense of $2.2.

### Corporate

The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in the third quarter of 2018 and 2017. The Corporate segment income before income taxes was $2.5 in the third quarter of 2018, as compared to $2.7 in the same period in 2017. The Corporate segment income before income taxes was $7.0 for the first nine months of 2018, as compared to $7.9 in the same period in 2017.

### Liquidity and Capital Resources

On March 29, 2018, we replaced our former $1,000.0 unsecured revolving credit facility that was scheduled to terminate on December 4, 2020 with a new $1,000.0 unsecured revolving credit facility (the “Credit Agreement”). Under the Credit Agreement, we have the ability to increase our borrowing up to an additional $600.0, subject to lender commitments and certain conditions as described in the Credit Agreement. Borrowings under the Credit Agreement are available for general corporate purposes and are used to support our $1,000.0 commercial paper program. Unless extended, the Credit Agreement will terminate and all amounts outstanding thereunder will be due and payable on March 29, 2023.

As of September 30, 2018, we had $188.3 in cash and cash equivalents, and approximately $996.7 available through the revolving facility under our Credit Agreement and our commercial paper program. To preserve our liquidity, we invest cash primarily in government money market funds, prime money market funds, short-term commercial paper and short-term bank deposits.

As a result of the Tax Act, we repatriated excess cash held at our foreign subsidiaries in 2018. We repatriated approximately $150.0 of the $194.0 that was held outside the U.S as of December 31, 2017.

The current economic environment presents risks that could have adverse consequences for our liquidity. See “Unfavorable economic conditions could adversely affect demand for our products” under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (the “Form 10-K”). We do not anticipate that current economic conditions will adversely affect our ability to comply with the financial covenant in the Credit Agreement because we currently are, and anticipate that we will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On February 5, 2018, the Board declared a 14% increase in the regular quarterly dividend from $0.19 to $0.2175 per share, equivalent to an annual dividend of $0.87 per share payable to stockholders of record as of February 15, 2018. The increase raises the annual dividend payout from $190.0 to approximately $215.0.

In connection with our share repurchase program authorized by the Board in November 2017 (the “2017 Share Repurchase Program”) and our evergreen repurchase program, we entered into an accelerated share repurchase (“ASR”) contract with a commercial bank in December of 2017 to purchase $200.0 of the Common Stock in the first quarter of 2018, of which approximately $110.0 was purchased under the evergreen share repurchase program and approximately $90.0 was purchased under the 2017 Share Repurchase Program.

We anticipate that our cash from operations, together with our current borrowing capacity, will be sufficient to meet our capital expenditure program costs, which are expected to be approximately $70.0 in 2018, fund our share repurchase programs to the extent implemented by management and pay dividends at the latest approved rate. Cash, together with our current borrowing capacity, may be used for acquisitions that would complement our existing product lines or geographic markets. We do not have any mandatory fixed rate debt principal payments in 2018. Our Floating Rate Senior Notes mature on January 25, 2019. We anticipate we will have sufficient liquidity to repay the notes.

#### Cash Flow Analysis

|  | Nine Months Ended September 30, 2018 | September 30, 2017 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$568.0** | $424.1 |
| Net cash used in investing activities | **$(82.3)** | $(1,278.3) |
| Net cash (used in) provided by financing activities | **$(574.1)** | $888.6 |

**Net Cash Provided by Operating Activities –** Our primary source of liquidity is the cash flow provided by operating activities, which is dependent on the level of net income and changes in working capital. Our net cash provided by operating activities in the nine months ended September 30, 2018 increased by $143.9 to $568.0 as compared to $424.1 in the same period in 2017 due to higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, non-cash compensation and asset impairment charges) and a decrease in working capital. The change in working capital is primarily due to an increase in accounts payable and accrued expenses as we continue to extend payment terms with our suppliers, an increase in taxes payable and incentive compensation and profit sharing accruals, partially offset by increases in inventory and accounts receivable. However, we measure working capital effectiveness based on our cash conversion cycle. The following table presents our cash conversion cycle information for the quarters ended September 30, 2018 and 2017:

|  | As of September 30, 2018 | September 30, 2017 | Change |
| --- | ---: | ---: | ---: |
| Days of sales outstanding in accounts receivable ("DSO") | 31 | 31 | 0 |
| Days of inventory outstanding ("DIO") | 59 | 53 | 6 |
| Days of accounts payable outstanding ("DPO") | 68 | 69 | 1 |
| Cash conversion cycle | 22 | 15 | 7 |

Our cash conversion cycle (defined as the sum of DSO and DIO less DPO) which is calculated using a two period average method, increased seven days from the prior year amount of 15 days to 22 days at September 30, 2018 due primarily to an increase in DIO of six days. DPO declined one day from 69 to 68 days and DSO remained consistent compared to the same period in 2017. The increase in the cash conversion cycle is primarily due to certain acquisitions, which currently require a higher level of working capital. We continue to focus on reducing our working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first nine months of 2018 was $82.3, primarily reflecting $49.8 for the Passport Acquisition, and $30.4 for property, plant and equipment additions. Net cash used in investing activities during the first nine months of 2017 was $1,278.3, primarily reflecting $1,024.7 for the Waterpik Acquisition, $160.3 for the Viviscal Acquisition, $75.0 for the Agro Acquisition and $20.9 for property, plant and equipment expenditures, partially offset by $4.5 of cash proceeds from the sale of the Brazil chemical business.

**Net Cash (Used in) Provided by Financing Activities –** Net cash used in financing activities during the first nine months of 2018 was $574.1, reflecting $200.0 of repurchases of our common stock (“Common Stock”), $159.6 of cash dividend payments, $269.5 of debt payments, partially offset by $58.0 of proceeds from stock option exercises. Net cash provided by financing activities during the first nine months of 2017 was $888.6, primarily reflecting $1,621.3 of long-term debt borrowings and $37.9 of proceeds from stock option exercises partially offset by $300.0 of repurchases of Common Stock, $200.0 of long-term debt repayments, $143.2 of cash dividend payments, $105.0 of net commercial paper repayments, $17.8 of financing costs and $4.6 of short-term debt repayments at an international subsidiary.

## Market risk

As filed, 346 characters.

### Market risk

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017. Our exposure to market risk has not changed materially since December 31, 2017.

## Controls and procedures

As filed, 5,985 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurring during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations; earnings per share; the impact of new accounting pronouncements; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of competitive laundry detergent products, including unit dose laundry detergent; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; actual voluntary and expected cash contributions to pension plans; impairments and other charges including the pension settlement charge and asset impairment charges; the Company’s investments in joint ventures; the impact of acquisitions and divestitures; capital expenditures; the Company’s effective tax rate; the impact of the Tax Cuts and Jobs Act; the impact of tax audits; tax changes and the lapse of applicable statutes of limitations; the effect of the credit environment on the Company’s liquidity and capital resources; the Company’s fixed rate debt; compliance with covenants under the Company’s debt instruments; the Company’s commercial paper program; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; and the Company’s share repurchase programs; payment of dividends; environmental and regulatory matters; and the availability and adequacy of raw materials, including trona reserves and the conversion of such reserves. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; delays or other problems in manufacturing or distribution; increases in transportation costs; adverse developments affecting the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; transition to, and shifting economic policies in the United States; potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs, including the actual and potential effect of tariffs on Chinese goods imposed by the United States Trade Representative; issues relating to the Company’s information technology and controls; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Nov 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001564590-18-026089. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
